LEUKINE
LEUKINE® (sargramostim) is the first and only FDA-approved GM-CSF that reduces the risk of infection-related outcomes after allogeneic and autologous BMT and improves survival after delayed or failed engraftment.1.
LEUKINE
Industry:
Biotechnology
Address:
Lynnwood, Washington, United States
Country:
United States
Website Url:
http://www.leukine.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Official Site Inspections
http://www.leukine.com Semrush global rank: 9.47 M Semrush visits lastest month: 152
- Host name: 38.127.92.75
- IP address: 38.127.92.75
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Leukine"
LEUKINE® (sargramostim)
LEUKINE (sargramostim) is a glycosylated recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) produced by recombinant DNA technology in yeast. LEUKINE …See details»
Prescribing Information - LEUKINE
LEUKINE is indicated to shorten time to neutrophil recovery and to reduce the incidence of severe, life-threatening, or fatal infections following induction chemotherapy in adult patients …See details»
Sargramostim - Wikipedia
Sargramostim is primarily used for myeloid reconstitution after autologous or allogeneic bone marrow transplantation. It is also used to treat neutropenia induced by chemotherapy during the treatment of acute myeloid leukemia. Additionally, it is used as a medical countermeasure for treating people who have been exposed to sufficient radiation to suppress bone marrow myelogenesis. See details»
LEUKINE® (sargramostim) | Resources
LEUKINE (sargramostim) is a glycosylated recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) produced by recombinant DNA technology in yeast. LEUKINE is indicated:See details»
Leukine (Partner Therapeutics, Inc.): FDA Package Insert
SPECIALTY GUIDELINE MANAGEMENT - Johns Hopkins Medicine
Leukine is indicated in adult patients with cancer undergoing autologous hematopoietic stem cell transplantation for the mobilization of hematopoietic progenitor cells into peripheral blood for …See details»
Leukine Injection: Uses, Dosage, Side Effects - Drugs.com
Sep 25, 2024 · Leukine is used in adults and children who are at least 2 years old, to help prevent serious infection in conditions such as leukemia, bone marrow transplant, and pre …See details»
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine ...
Commercial-stage cancer biotech company, Partner Therapeutics, Inc. (PTx), announced the recent FDA approval of Leukine for the treatment of adult and pediatric patients acutely …See details»
Frequently Asked Questions About Leukine …
Jun 1, 2018 · Leukine is FDA approved for increasing the number and function of white blood cell levels following chemotherapy for acute myelogenous leukemia in older patients, and after bone marrow transplant and autologous stem cell …See details»
Partner Therapeutics Announces Publication of Two Studies …
Feb 18, 2021 · - Studies Showed Statistically Significant Improvements in Survival in Subjects Treated with Leukine Starting 48 Hours After Acute, High Dose Radiation Exposure without …See details»
Partner Therapeutics Announces Publication of Clinical Trial …
LEXINGTON, MA – May 19, 2021 — Partner Therapeutics, Inc. (PTx), a commercial biotech company, announces the publication of results from an investigator-initiated clinical trial …See details»
Scientists launch follow-on study to understand Leukine's
Oct 20, 2021 · Whatever you call it, the little-prescribed drug approved 30 years ago to boost white blood cell production among bone-marrow transplant patients shows increasing promise …See details»
DESCRIPTION - HemOnc.org
LEUKINE is indicated in patients who have undergone allogeneic or autologous bone marrow transplantation (BMT) in whom engraftment is delayed or has failed. LEUKINE has been found …See details»
Leukine - Chemocare
SARGRAMOSTIM (sar GRAM oh stim) lowers the risk of infection in people who are receiving chemotherapy. It works by helping your body make more white blood cells, which protects …See details»
Article Reviews 30-year History of Leukine and its Potential in ...
Leukine (sargramostim) is a yeast-derived recombinant human granulocyte-macrophage colony stimulating factor (rhuGM-CSF) and is approved by the US Food and Drug Administration …See details»
Leukine - Side Effects, Uses, Dosage, Overdose, Pregnancy, Alcohol …
Nov 8, 2013 · Leukine is a prescription medication used to to help your bone marrow make more white blood cells in certain situations such as after chemotherapy. Leukine belongs to a group …See details»
Your treatment recommendation: Leukine® - Wicha Lab
Leukine® is a medication that you will inhale (breathe in) once a day through a nebulizer. A nebulizer is a device that delivers medication in the form of a mist that you inhale into your …See details»
Leukine® is beneficial to patients with mild-to-moderate Alzheimer’s
Mar 25, 2021 · In a Phase II trial, Leukine® (sargramostim) significantly reduced biomarkers of neurodegeneration and improved cognitive function.See details»
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - Leukine
LEUKINE is indicated to increase survival in adult and pediatric patients from birth to 17 years of age acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of …See details»
Leukine: Uses, Taking, Side Effects, Warnings - Medicine.com
Sep 15, 2020 · Leukine is a man-made form of granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF is a substance produced by the body. It stimulates the growth of certain …See details»